Context Therapeutics Inc.·4

Aug 17, 5:22 PM ET

Sahmoud Tarek 4

4 · Context Therapeutics Inc. · Filed Aug 17, 2022

Insider Transaction Report

Form 4
Period: 2022-08-16
Sahmoud Tarek
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2022-08-16$1.95/sh+10,000$19,50010,000 total

Documents

1 file
  • 4
    wf-form4_166077134963058.xmlPrimary

    FORM 4